Nanox to deploy lung cancer screening system at Paris hospital

PETACH TIKVA, Israel - Nano-X Imaging Ltd (NASDAQ:NNOX), a $186.7 million market cap medical imaging technology company whose shares have declined nearly 48% over the past six months, announced Friday it will deploy its Nanox.ARC imaging system at Hospital Privé Jacques Cartier MASSY near Paris through a collaboration with Olympe Imagerie, a group of independent radiologists.

The multi-source digital tomosynthesis system, which received CE Mark certification in February 2025, will be used for clinical trials focused on lung cancer detection and screening applications.

Olympe Imagerie provides imaging services at multiple centers across the Ile-de-France region, collectively serving over 400,000 patients annually.

"France is an important market for our European expansion strategy, and this collaboration advances our clinical validation efforts in a key geography," said Erez Meltzer, CEO and Acting Chairman of Nanox.

Romain Pommier, Associate Radiologist at Olympe Imagerie, stated, "We are proud to collaborate with Nanox and to be among the first in Europe to evaluate this new imaging system. Lung cancer screening remains one of the most important applications in diagnostic radiology."

The Nanox.ARC system utilizes 3D imaging technology designed to provide diagnostic capabilities at lower costs than traditional systems. Following its European regulatory clearance earlier this year, the device is now being positioned for clinical evaluation in France.

The company said in its press release that the system is already en route to France as Nanox works to strengthen its European clinical and commercial presence.

In other recent news, Nano-X Imaging has maintained its Overweight rating with a price target of $6.00, according to Cantor Fitzgerald. This follows the company’s announcement of a new healthcare collaboration. Nano-X Imaging has entered into a multi-segment partnership with Monarch Medical Management and Billing LLC. This collaboration aims to deploy Nano-X Imaging’s solutions across various healthcare facilities, including workers’ compensation centers, nursing homes, and outpatient clinics. These developments are part of the company’s ongoing efforts to expand its reach in the healthcare sector. The partnership is expected to enhance the accessibility of imaging solutions in diverse medical environments. Cantor Fitzgerald’s continued confidence in Nano-X Imaging reflects the potential seen in these strategic moves.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.